Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Gonzalez-Cao M, Puertolas T, Riveiro M, Muñoz-Couselo E, Ortiz C, Paredes R, Podzamczer D, Manzano JL, Molto J, Revollo B, Carrera C, Mateu L, Fancelli S, Espinosa E, Clotet B, Martinez-Picado J, Cerezuela P, Soria A, Marquez I, Mandala M, Berrocal A; Spanish Melanoma Group (GEM). Gonzalez-Cao M, et al. Among authors: molto j. J Immunother Cancer. 2021 Mar;9(3):e001664. doi: 10.1136/jitc-2020-001664. J Immunother Cancer. 2021. PMID: 33782108 Free PMC article. Review.
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.
Moltó J, Valle M, Ferrer E, Domingo P, Curran A, Santos JR, Mateo MG, Di Yacovo MS, Miranda C, Podzamczer D, Clotet B; DRV600 Study Group. Moltó J, et al. J Antimicrob Chemother. 2015 Apr;70(4):1139-45. doi: 10.1093/jac/dku516. Epub 2014 Dec 18. J Antimicrob Chemother. 2015. PMID: 25525195 Clinical Trial.
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
Santos JR, Llibre JM, Berrio-Galan D, Bravo I, Miranda C, Pérez-Alvarez S, Pérez-Alvarez N, Paredes R, Clotet B, Moltó J. Santos JR, et al. Among authors: molto j. J Antimicrob Chemother. 2015 Apr;70(4):1124-9. doi: 10.1093/jac/dku509. Epub 2014 Dec 18. J Antimicrob Chemother. 2015. PMID: 25525196
Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.
Di Yacovo MS, Moltó J, Ferrer E, Curran A, Else L, Gisslén M, Clotet B, Tiraboschi JM, Niubò J, Vila A, Zetterberg H, Back D, Podzamczer D. Di Yacovo MS, et al. Among authors: molto j. J Antimicrob Chemother. 2015 May;70(5):1513-6. doi: 10.1093/jac/dku558. Epub 2015 Jan 20. J Antimicrob Chemother. 2015. PMID: 25608583 Clinical Trial.
Determinants of virological failure and antiretroviral drug resistance in Mozambique.
Rupérez M, Pou C, Maculuve S, Cedeño S, Luis L, Rodríguez J, Letang E, Moltó J, Macete E, Clotet B, Alonso P, Menéndez C, Naniche D, Paredes R. Rupérez M, et al. Among authors: molto j. J Antimicrob Chemother. 2015 Sep;70(9):2639-47. doi: 10.1093/jac/dkv143. Epub 2015 Jun 16. J Antimicrob Chemother. 2015. PMID: 26084302
Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial.
Santos JR, Llibre JM, Bravo I, García-Rosado D, Cañadas MP, Pérez-Álvarez N, Paredes R, Clotet B, Moltó J. Santos JR, et al. Among authors: molto j. AIDS Res Hum Retroviruses. 2016 May;32(5):452-5. doi: 10.1089/AID.2015.0248. Epub 2016 Feb 11. AIDS Res Hum Retroviruses. 2016. PMID: 26781004 Clinical Trial.
281 results